Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Below-the-knee disease with the clinical presentation of critical limb ischemia is associated with a high rate of limb loss due to minor and major amputations. The consequences that these patients ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

FDA approves a 76-mm version of Abbott’s Esprit BTK resorbable scaffold system for patients with CLTI. The longer scaffold is intended to reduce the number of devices needed to treat long BTK lesions ...

Coils and plugs have emerged as the most commonly employed mechanical embolic devices. Various coils are used in daily practice for an array of clinical applications. Although effective, the main ...

Fenestrated and branched endovascular aortic repair (F/BEVAR) has become widely accepted as an alternative to open surgical repair for treatment of complex abdominal aortic aneurysms (AAAs). The ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...

During the past 15 years, the treatment of type B aortic dissection has evolved after the introduction of thoracic endovascular aortic repair (TEVAR). With high success rates and acceptable clinical ...

HistoSonics announced that it has received approval in Europe for its Edison system, enabling the commercialization of the ...

Percutaneous transluminal peripheral angioplasty (PTA), with and without stenting, is an effective, accepted, and safe approach for treating iliac artery occlusive disease. Complications, although ...

Xeltis announced the official start of the European commercialization of aXess vascular access device for patients requiring hemod ...